New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
08:59 EDTYHOO, CVM, NBG, WBMD, ICPT, ACOR, LXRX, MDT, EW, FB, C, AKBAOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Citigroup (C), up 3.7%. ALSO HIGHER: Yahoo (YHOO), up 1.7% after upgraded to Buy from Neutral at SunTrust... Facebook (FB), up 2.5% after Financial Times reports company looking to provide financial services... Lexicon (LXRX), up 19.5% after achieving positive results in Type 1 diabetes clinical trial... Akebia (AKBA), up 13.8% after initiated at Nomura, Credit Suisse, Morgan Stanley and UBS... WebMD (WBMD), up 10% after saying it now sees Q1 adjusted EBITDA to come in above the high end of its previous guidance... Intercept (ICPT), up 4.9% after reporting additional data from POISE trial at EASL... Ewards Lifesciences (EW), up 11.3% after a district court granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the U.S. Medtronic shares down 5.2% following the news. ALSO LOWER: National Bank of Greece (NBG), down 10.7% after Reuters says bank selected Goldman Sachs (GS) and Morgan Stanley (MS) as global coordinators for a planned equity offering... : CEL-SCI (CVM), down 10.6% after announcing intent to offer common stock, six month warrants in 'best efforts' offering... Acorda Therapeutics (ACOR), down 6.2% after pushing off start of Phase 3 study of dalfampridine-QD to second half of year.
News For YHOO;C;FB;EW;MDT;LXRX;ACOR;ICPT;WBMD;NBG;CVM;AKBA From The Last 14 Days
Check below for free stories on YHOO;C;FB;EW;MDT;LXRX;ACOR;ICPT;WBMD;NBG;CVM;AKBA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
July 18, 2014
13:39 EDTYHOOYahoo News hires Golodryga to head up news and finance properties, Variety says
Subscribe for More Information
12:51 EDTMDTKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
12:21 EDTFBCable ad upfront volumes may drop 4% or more, WSJ says
Two of the U.S.'s biggest marketers, Procter & Gamble (PG) and General Motors (GM), have pulled back on their TV network advertising commitments in advance of the "upfront" selling season for cable networks, said The Wall Street Journal, citing people familiar with the matter. The overall volume of ad dollars committed to cable networks during the upfront, which is still under way, could be down 4% or more from last year, people familiar with the situation said. Notable owners of cable television stations include 21st Century Fox (FOXA), Time Warner (TWX), Disney (DIS), CBS (CBS), Comcast (CMCSA), Discovery (DISCA), Viacom (VIAB), and AMC Networks (AMCX). The report added that cutbacks partly reflect a shift of tv ad budgets to digital media, including online video. Google (GOOG) has a large presence in online video with YouTube and Facebook (FB) is taking steps to grow in the area. Reference Link
12:05 EDTFBStocks with call strike movement; FB YNDX
Facebook (FB) January 80 call option implied volatility decreased 3% to 36, Yandex (YNDX) January 37 call option implied volatility decreased 6% to 36 according to IVolatility.
12:01 EDTCCitigroup says DOJ settlement includes est. of cost of consumer relief
Says $3.8B charge for DOJ settlement included estimates of cost of consumer relief.
11:30 EDTCCitigroup sees issuing 'somewhat more' securitizations during rest of year
Says liquidity position remains strong. Sees FY NCL rate in Asia, Latin America roughly in line with 1H. Says expects to repurchase or redeem $10B of debt this year. Expects to issue preferred stock between now and when Basel III rules are implemented at a measured pace. Sees 2014 preferred stock issuance volume below 2013 levels. Says capital position remains among the strongest in the industry. Says will issue "somewhat more" securitizations during the rest of the year, says credit cards to be primary source of additional securitizations. Comments made on the company's Q2 Fixed Income Investor Review.
11:25 EDTYHOOOptions with decreasing implied volatility
Subscribe for More Information
10:32 EDTCCitigroup says making continued progress in resolving legacy issues
Subscribe for More Information
09:48 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL NQ GOOG GOOGL TSLA KGC TWTR AMZN ELNK AMGN FB
06:48 EDTFBJapan mobile messaging service pursues U.S. IPO, Bloomberg says
Subscribe for More Information
July 17, 2014
16:01 EDTFBOptions Update; July 17, 2014
iPath S&P 500 VIX Short-Term Futures up 2.66 to 29.93. Option volume leaders: AAPL FB GOOG APA MSFT PBR SUNE AMZN TWTR TSLA according to Track Data.
14:52 EDTYHOOYahoo Sports, NBC Sports announce expanded fantasy football coverage
Subscribe for More Information
14:28 EDTFBFacebook testing new 'Buy Button' feature to facilitate purchases
Subscribe for More Information
11:12 EDTYHOOOptions with decreasing implied volatility
Subscribe for More Information
11:07 EDTACORAcorda sues Mylan over plans to duplicate Ampyra MS drug, Bloomberg says
10:14 EDTFBFacebook view changed to Positive from Neutral at OTR Global (pre-open)
Subscribe for More Information
09:40 EDTFBActive equity options trading on open
Subscribe for More Information
08:45 EDTCVMCEL-SCI expands Phase III head and neck cancer trial into Sri Lanka
CEL-SCI announced that Sri Lanka’s Ministry of Health has cleared the company to commence patient enrollment for its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine in Sri Lanka. This follows similar clearance to conduct the Phase III study in the UK and Austria during the past weeks. Further expansion of the trial is underway with a goal to have a total of 880 patients enrolled through about 100 clinical centers in 20 countries by the end of 2015. The trial, which already has over 220 patients enrolled, is assessing the company’s investigational immunotherapeutic agent Multikine as a potential first-line treatment for advanced primary head and neck cancer. If approved for use following completion of CEL-SCI's clinical development program for head and neck cancer, Multikine would be a different type of therapy in the fight against cancer; one that appears to have the potential to work with the body's natural immune system in the fight against tumors.
08:42 EDTYHOOCBS, Yahoo among potential CNN buyers if Time Warner divests, WSJ says
If Time Warner (TWX) were to divest CNN, which has been raised as a possiblity given the interest in Time Warner expressed by Fox News owner 21st Century Fox (FOXA), the "long list of potential buyers" would include CBS (CBS), Yahoo (YHOO) and Bloomberg LP, said The Wall Street Journal, citing media analysts and executives. Reference Link
06:50 EDTFBAirbus considering partnering with high tech companies, NY Times says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use